Peginterferon alfa-2a
PEGASYS (peginterferon alfa-2a) is a prescription medication manufactured by pharmaand GmbH, classified as an interferon alpha. It's administered via subcutaneous injection and comes in syringe or vial forms with strengths like 180 mcg per dose. This drug is used to treat conditions such as chronic hepatitis C. This information was generated using AI and is provided for informational and research purposes only.
Complete Metadata
| @type | dcat:Dataset |
|---|---|
| accessLevel | public |
| accrualPeriodicity | R/P1Y |
| bureauCode |
[
"009:10"
]
|
| contactPoint |
{
"fn": "Division of Drug Information",
"@type": "vcard:Contact",
"hasEmail": "mailto:druginfo@fda.hhs.gov"
}
|
| description | PEGASYS (peginterferon alfa-2a) is a prescription medication manufactured by pharmaand GmbH, classified as an interferon alpha. It's administered via subcutaneous injection and comes in syringe or vial forms with strengths like 180 mcg per dose. This drug is used to treat conditions such as chronic hepatitis C. This information was generated using AI and is provided for informational and research purposes only. |
| distribution |
[
{
"@type": "dcat:Distribution",
"title": "Peginterferon alfa-2a",
"mediaType": "text/html",
"description": "
Access the FDA dataset for Peginterferon alfa-2a — ANDA 103964 submitted by Mylan Institutional LLC
",
"downloadURL": "https://www.accessdata.fda.gov/scripts/cder/daf/index.cfm?event=overview.process&ApplNo=103964"
}
]
|
| identifier | ANDA103964 |
| issued | 2016-09-16 |
| keyword |
[
"drug-information",
"drug-manufacturers",
"drug-safety",
"prescription-drugs",
"public-health"
]
|
| landingPage | https://www.fda.gov/drugs |
| license | https://open.fda.gov/license |
| modified | 2025-03-17 |
| programCode |
[
"009:002"
]
|
| publisher |
{
"name": "U.S. Food and Drug Administration",
"@type": "org:Organization"
}
|
| theme |
[
"FDA"
]
|
| title | Peginterferon alfa-2a |
